Loxo Oncology (LOXO) PT Lowered to $108 at Citi on Bayer Collaboration for Laro & LOXO-195; 'Deal Not Exactly What We Expected, But Still Very Good'

November 15, 2017 6:54 AM

Citi lowered its price target on Loxo Oncology (NASDAQ: LOXO) to $108.00 (from $112.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

Loxo Oncology (LOXO) PT Lowered to $108 at Citi on Bayer Collaboration for Laro & LOXO-195; 'Deal Not Exactly What We Expected, But Still Very Good'

Categories

Next Articles